RxDoctor Payments Data

Wolfgang Kienzle, DPM

Podiatrist · Oklahoma City, OKNPI 1407420862

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Integra Lifesciences Corporation at 39.4% of the total. That places this record below the midpoint for podiatrist clinicians in OK, where the typical reported total is $1,579.

$1,566in general payments, 2019–2025

Across 31 payments — averaging $50.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$617
  • Stryker$298
  • Smith+Nephew$259
  • Nevro Corp.$142
  • Pylant Medical$130
  • Treace Medical Concepts, Inc.$56
  • plus $65 from 3 others

What the payments were for

  • Food & beverage$1,566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,566 in reported general payments places this provider in the 45th percentile of 54 podiatrist providers in Oklahoma.

See all podiatrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$21,446
Medicare patients
177
Services billed
356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$333
Cephalexin14$46

Paid to pharmacies, not to this prescriber.

Other podiatrist in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →